MSSP Public Reporting Page

 

 

ACO Name and Location

Palmetto Health Quality Collaborative, LLC
1301 Taylor Street
STE 9A
Columbia, South Carolina 29201

 

ACO Primary Contact

Primary Contact Name

Sarah Perry Orsinger

Primary Contact Phone Number

803-296-2352

Primary Contact Email Address

Sarah.Orsinger@PalmettoHealth.org

 

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture

Professional Pathology Services PC

N

Plastic Surgery Consultants, LLC

N

Wellspring Family Medicine

N

Donen Davis Plastic Surgery, LLC

N

Carolina Kidney Specialists, LLC

N

South Carolina ENT Allergy & Sleep Medicine PA

N

Pierre Jaffe

N

Kraemer Womens Care

N

Elgin Podiatry Institute, LLC

N

University Specialty Clinics - Neurology

N

Sandhills OBGYN Associates, P.A.

N

Cardiology Associates of Sumter LLC

N

Palmetto Health Tuomey Home Health

N

Columbia Heart Clinic

N

SC OB-GYN Associates PA

N

Centa Medical Group PA

N

Columbia Urological Associates, P.A.

N

Carolina Anesthesiology Associates, PA

N

Pinner Clinic

N

Midland Ear Nose and Throat

N

University Specialty Clinics - Surgery

N

University Specialty Clinics - Neuropsychiatry and Behavioral Science

N

University Pediatrics

N

Department of Internal Medicine

N

South Carolina Oncology Assoc Pa

N

MCCAIN ORTHOPAEDIC CLINIC

N

South Carolina Neurological Clinic PA

N

University Specialty Clinics - Obstetrics/Gynecology

N

Palmetto Retina Center LLC

N

University Specialty Clinics - Orthopaedics

N

University Specialty Clinic, Dept. Family & Preventive Medicine

N

Tuomey Medical Professionals, Inc

N

Carolina Allergy & Asthma Consultants

N

Palmetto Family Practice, LLC

N

The Dermatology Group LLC

N

Palmetto Health

N

 

ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Gerard

William (Bill)

MD, Chair

1

ACO Participant Representative

Palmetto Health

Metropol

Stephen

MD, Vice Chair

1

ACO Participant Representative

Palmetto Health

Beaman

Charles

Secretary

1

ACO Participant Representative

Palmetto Health

Duke

Jean

Treasurer

1

ACO Participant Representative

Palmetto Health

Hall

Leslie

MD

1

ACO Participant Representative

Department of Internal Medicine

Kudrik

Fred

MD

1

ACO Participant Representative

South Carolina Oncology Assoc Pa

Odom, Jr.

Albert

MD

1

ACO Participant Representative

Palmetto Health

Petit

Scott

MD

1

ACO Participant Representative

Palmetto Health

Stands

James

MD

1

ACO Participant Representative

SC OB-GYN Associates PA

Williams

Roman

MD

1

ACO Participant Representative

Carolina Anesthesiology Associates, PA

Brannigan

Joseph

MD

1

Other Entity Representative

Columbia Nephrology Associates, PA

Wessinger

Kevin

MD

1

Other Entity Representative

South Carolina Pediatric Alliance

 

Key ACO clinical and administrative leadership:

Judy Baskins

ACO Executive

Bill Gerard

Medical Director

Judy Baskins

Compliance Officer

Anna Kay

Quality Assurance/Improvement Officer

 

Associated committees and committee leadership: 

Committee Name

Committee Leader Name and Position

Participation and Performance Evaluation

William Gerard, MD, Chair

Clinical Initiatives Committee

Mark Mayson, MD, Chair

Finance and Payer Relations

Jeff Haladay, MD, Chair

Executive Committee

William Gerard, MD, Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO: 

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

 

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

81.91

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

94.05

92.63

ACO-3

CAHPS: Patients' Rating of Provider

93.97

91.93

ACO-4

CAHPS: Access to Specialists

83.24

83.52

ACO-5

CAHPS: Health Promotion and Education

58.04

60

ACO-6

CAHPS: Shared Decision Making

74.57

75.28

ACO-7

CAHPS: Health Status/Functional Status

70.9

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

27.11

27.52

ACO-8

Risk-Standardized, All Condition Readmission

14.14

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

17.83

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

47.3

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

79.26

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

58.76

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

9.5

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

13.41

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

75.21

82.72

ACO-39

Documentation of Current Medications in the Medical Record

53.86

87.54

ACO-13

Falls: Screening for Future Fall Risk

33.33

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

66.67

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

68.95

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

60.08

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

54

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

29.03

53.63

ACO-19

Colorectal Cancer Screening

55.65

61.52

ACO-20

Breast Cancer Screening

65.32

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

63.77

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

73.86

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

16.62

18.24

ACO-41

Diabetes: Eye Exam  

34.12

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

68.31

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

80.69

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

79.62

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

70.45

79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Note: In the Quality Performance Results file(s) above, search for “Palmetto Health Quality Collaborative, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A99911 in the public use files on data.cms.gov.

 

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.